Related Experiment Video
Updated: Oct 20, 2025

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Diagnostic Scores and Treatment Options for Acute Disseminated Intravascular Coagulation in Children
Saru Kunwar1, Mohammad Alam2, Francis Ezekwueme2
1Internal Medicine/Pediatrics, California Institute of Behavioral Neurosciences & Psychology, California, USA.
Insights
Pediatric disseminated intravascular coagulation (DIC) management requires tailored approaches due to unique hemostatic differences in children. This review highlights diagnostic scoring and treatment options for acute pediatric DIC.
Area of Science:
- Pediatric Hematology
- Thrombo-hemorrhagic Disorders
- Critical Care Medicine
Background:
- Disseminated intravascular coagulation (DIC) is a severe condition in critically ill children, leading to high morbidity and mortality.
- Current DIC management relies on treating underlying causes, hemodynamic support, and blood component replacement.
- Limited research exists on specific pediatric DIC diagnostic tools and treatments, unlike in adults.
Purpose of the Study:
- To review diagnostic scoring systems for pediatric DIC.
- To discuss pharmacological treatment options for acute DIC in children.
- To identify gaps in research and emphasize the need for pediatric-specific studies.
Main Methods:
- A comprehensive literature review was conducted using PubMed, Cochrane database, and Google Scholar.
- Over 100 articles published between 1990 and 2021 were analyzed.
- Focus was on human studies concerning pediatric DIC diagnosis and treatment.
Main Results:
- Diagnostic scoring systems for pediatric DIC require further validation.
- Limited evidence supports specific adjunctive therapies like antithrombin (AT), recombinant thrombomodulin (rTM), and protein C concentrates (PrCC) in children.
- Pediatric and neonatal hemostatic systems differ significantly from adults, necessitating distinct management strategies.
Conclusions:
- Pediatric DIC management necessitates specialized approaches distinct from adult protocols.
- There is a critical need for high-quality research to establish evidence-based guidelines for pediatric DIC.
- Further investigation into diagnostic criteria and therapeutic interventions is crucial for improving outcomes in children with DIC.
Abstract:
Disseminated intravascular coagulation (DIC) is a thrombo-hemorrhagic condition that commonly accompanies life-threatening illnesses in children and is associated with significant morbidity and mortality. Treatment of underlying conditions, hemodynamic support, and replacement therapy with blood components is the mainstay of DIC management. Limited research studies have supported the use of antithrombin (AT), recombinant thrombomodulin (rTM), and protein C concentrates (PrCC). Although there have been several studies and advancements in the DIC treatment in adults, data in pediatric patients are limited, and the consensus is lacking. Evidence validating the use of diagnostic scoring systems in the pediatric population is also limited. Since the hemostatic system differs significantly in children, especially in neonates, management of DIC is also different in children from that of adults, and there is a dire need for good quality research studies in this aspect. We reviewed more than 100 articles in PubMed, Cochrane database, and Google Scholar. This traditional review article discusses different scoring systems for diagnosing DIC in pediatric patients, and different pharmacological treatment options for acute DIC in this population. This study mainly focuses on papers published from 1990 to 2021 and includes papers in all languages involving humans only.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Anticoagulant Drugs: Low-Molecular-Weight Heparins

